Search by Drug Name or NDC
NDC 47781-0683-30 Rasagiline 0.5 mg/1 Details
Rasagiline 0.5 mg/1
Rasagiline is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alvogen, Inc.. The primary component is RASAGILINE MESYLATE.
MedlinePlus Drug Summary
Rasagiline is used alone or in combination with another medication to treat the symptoms of Parkinson's disease (a slowly progressing disease of the nervous system causing a fixed face without expression, tremor at rest, slowing of movements, walking with shuffling steps, stooped posture and muscle weakness). Rasagiline is in a class of medications called monoamine oxidase (MAO) type B inhibitors. It works by increasing the amounts of certain natural substances in the brain.
Related Packages: 47781-0683-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rasagiline
Product Information
| NDC | 47781-0683 |
|---|---|
| Product ID | 47781-683_cd461dbf-4155-fd7f-1815-5dd5d2cdfc94 |
| Associated GPIs | 73300025200320 |
| GCN Sequence Number | 060915 |
| GCN Sequence Number Description | rasagiline mesylate TABLET 0.5 MG ORAL |
| HIC3 | H6A |
| HIC3 Description | ANTIPARKINSONISM DRUGS,OTHER |
| GCN | 27081 |
| HICL Sequence Number | 032911 |
| HICL Sequence Number Description | RASAGILINE MESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Rasagiline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Rasagiline |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | RASAGILINE MESYLATE |
| Labeler Name | Alvogen, Inc. |
| Pharmaceutical Class | Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA201970 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 47781-0683-30 (47781068330)
| NDC Package Code | 47781-683-30 |
|---|---|
| Billing NDC | 47781068330 |
| Package | 30 TABLET in 1 BOTTLE, PLASTIC (47781-683-30) |
| Marketing Start Date | 2019-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.64267 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | RASAGILINE MESYLATE 0.5 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis